QRS duration as a novel prognostic ECG marker in hypertrophic cardiomyopathy

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Konstantinos Fragkiadakis

University Hospital of Heraklion, Heraklion (Greece)

10 More presentations in this session

Presentation thumbnail

Discussant - Hypertrophic cardiomyopathy

Presentation thumbnail

Left atrial strain and peak left ventricular outflow gradient are the main predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy

Doctor I. Cergan (Bucharest, RO)

Abstract Slides Video

Presentation thumbnail

A bayesian diagnostic-accuracy meta-analysis on hypertrophic cardiomyopathy diagnosis with the use of machine learning

Mr L. Puglla Sanchez (Zaragoza, ES)

Abstract Slides Video

Presentation thumbnail

Left atrial mechanics and the risk of atrial fibrillation in patients with hypertrophic cardiomyopathy

Doctor C. Mann (Vienna, AT)

Presentation thumbnail

Association of triglyceride-glucose index with all-cause and cardiovascular mortality in patients with hypertrophic cardiomyopathy: A multicenter cohort study

Doctor Y. Zheng (Tianjin, CN) Doctor T. Liu (Tianjin, CN)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (1) - Hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Exploring the association of electrocardiographic markers and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis

Congress Presentation

Native QRS duration and outcomes in heart failure with mildly reduced ejection fraction: results from a large-scaled registry

Congress Session

Novel risk predictors in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources